All have "statin" at the end
Lowers LDL
Competitively inhibits HMG-CoA reductase (which is the rate limiting step of cholesterol synthesis that converts HMG-CoA to mevalonate)
Increases LDL receptors (to remove LDL from circulation)
Improve in efficacy over time
New Drugs (PITA AT ROSie's); Synthetic; active and more potent metabolites, longer t1/2, pleiotropy (improve other stuff too-platelet function, blood viscosity, leukocyte adhesiveness), $$
Highly protein bound, except pravastatin (50%)
CYP3A4 incteractions except pravastatin (none) and fluvastatin (2C9)
"PRavastatin=Private"-No interactoins with protein or CYP3A4's
Low compliance (patients don't feel better)
SE: Increased liver transaminases, Myopathy (CK<10x normal), Rhabdomyolysis->toxic components into blood and cardiac arrest (CK>10x normal)
|